Genocea Biosciences Price Prediction
| GNCADelisted Stock | USD 0.0002 0.0001 100.00% |
Oversold Vs Overbought
67
Oversold | Overbought |
Using Genocea Biosciences hype-based prediction, you can estimate the value of Genocea Biosciences from the perspective of Genocea Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Genocea Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Genocea because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Genocea Biosciences after-hype prediction price | USD 2.5E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genocea |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genocea Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Genocea Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Genocea Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genocea Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genocea Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Genocea Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Genocea Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genocea Biosciences' historical news coverage. Genocea Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Genocea Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Genocea Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Genocea Biosciences is based on 3 months time horizon.
Genocea Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Genocea Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genocea Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genocea Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 4 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0002 | 0.0003 | 25.00 |
|
Genocea Biosciences Hype Timeline
Genocea Biosciences is currently traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Genocea is forecasted to increase in value after the next headline, with the price projected to jump to 2.5E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 25.0%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Genocea Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.00. Genocea Biosciences currently holds 8.79 M in liabilities with Debt to Equity (D/E) ratio of 1.25, which is about average as compared to similar companies. Genocea Biosciences has a current ratio of 1.32, which is within standard range for the sector. Note, when we think about Genocea Biosciences' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.Genocea Biosciences Related Hype Analysis
Having access to credible news sources related to Genocea Biosciences' direct competition is more important than ever and may enhance your ability to predict Genocea Biosciences' future price movements. Getting to know how Genocea Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genocea Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ECPG | Encore Capital Group | (0.73) | 8 per month | 0.00 | (0.08) | 2.57 | (2.42) | 9.26 | |
| MAHN | Mid Atlantic Home Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIVE | Live Ventures | (0.49) | 4 per month | 0.00 | (0.27) | 5.98 | (5.86) | 16.34 | |
| UHG | United Homes Group | 0.11 | 5 per month | 3.39 | 0.02 | 7.79 | (5.63) | 17.32 | |
| MHO | MI Homes | 2.34 | 6 per month | 2.39 | (0.03) | 3.69 | (4.24) | 10.66 | |
| AROW | Arrow Financial | 0.84 | 9 per month | 1.71 | 0.02 | 3.64 | (3.25) | 17.84 | |
| GBCI | Glacier Bancorp | 0.55 | 6 per month | 1.66 | 0.1 | 3.88 | (3.32) | 14.43 |
Genocea Biosciences Additional Predictive Modules
Most predictive techniques to examine Genocea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genocea using various technical indicators. When you analyze Genocea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Genocea Biosciences Predictive Indicators
The successful prediction of Genocea Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genocea Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genocea Biosciences based on analysis of Genocea Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genocea Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genocea Biosciences's related companies.
Story Coverage note for Genocea Biosciences
The number of cover stories for Genocea Biosciences depends on current market conditions and Genocea Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genocea Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genocea Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Genocea Biosciences Short Properties
Genocea Biosciences' future price predictability will typically decrease when Genocea Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Genocea Biosciences often depends not only on the future outlook of the potential Genocea Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genocea Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 68.6 M | |
| Cash And Short Term Investments | 37.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Genocea Stock
If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |